113 related articles for article (PubMed ID: 34303080)
1. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics.
Gong Q; Yang F; Hu J; Li T; Wang P; Li X; Zhang X
Eur J Med Chem; 2021 Nov; 224():113707. PubMed ID: 34303080
[TBL] [Abstract][Full Text] [Related]
2. Chemiluminescent Probe for the In Vitro and In Vivo Imaging of Cancers Over-Expressing NQO1.
Son S; Won M; Green O; Hananya N; Sharma A; Jeon Y; Kwak JH; Sessler JL; Shabat D; Kim JS
Angew Chem Int Ed Engl; 2019 Feb; 58(6):1739-1743. PubMed ID: 30561862
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
Punganuru SR; Madala HR; Arutla V; Zhang R; Srivenugopal KS
Sci Rep; 2019 Jun; 9(1):8577. PubMed ID: 31189950
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents.
Wu LQ; Ma X; Liu ZP
Bioorg Chem; 2021 Aug; 113():104995. PubMed ID: 34034133
[TBL] [Abstract][Full Text] [Related]
5. Azo-based near-infrared fluorescent theranostic probe for tracking hypoxia-activated cancer chemotherapy in vivo.
Ding N; Li Z; Tian X; Zhang J; Guo K; Wang P
Chem Commun (Camb); 2019 Oct; 55(87):13172-13175. PubMed ID: 31620737
[TBL] [Abstract][Full Text] [Related]
6. Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation.
Bian J; Li X; Xu L; Wang N; Qian X; You Q; Zhang X
Eur J Med Chem; 2017 Feb; 127():828-839. PubMed ID: 27829520
[TBL] [Abstract][Full Text] [Related]
7. Distinct responses of compartmentalized glutathione redox potentials to pharmacologic quinones targeting NQO1.
Kolossov VL; Ponnuraj N; Beaudoin JN; Leslie MT; Kenis PJ; Gaskins HR
Biochem Biophys Res Commun; 2017 Jan; 483(1):680-686. PubMed ID: 27986568
[TBL] [Abstract][Full Text] [Related]
8. Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation.
Li X; Bian J; Wang N; Qian X; Gu J; Mu T; Fan J; Yang X; Li S; Yang T; Sun H; You Q; Zhang X
Bioorg Med Chem; 2016 Mar; 24(5):1006-13. PubMed ID: 26803578
[TBL] [Abstract][Full Text] [Related]
9. A near-infrared fluorescent probe with two-photon excitation for in situ imaging of NQO1 in human colorectum cancer tissue.
Jiang W; An W; Huang Z; Xu C; Shen Q; Pu C; Zhang S; Wu Q; Li L; Yu C
Talanta; 2024 Jul; 274():126018. PubMed ID: 38593645
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X
Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663
[TBL] [Abstract][Full Text] [Related]
11. A direct interaction between NQO1 and a chemotherapeutic dimeric naphthoquinone.
Pidugu LS; Mbimba JC; Ahmad M; Pozharski E; Sausville EA; Emadi A; Toth EA
BMC Struct Biol; 2016 Jan; 16():1. PubMed ID: 26822308
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer.
Wu X; Li X; Li Z; Yu Y; You Q; Zhang X
J Med Chem; 2018 Dec; 61(24):11280-11297. PubMed ID: 30508483
[TBL] [Abstract][Full Text] [Related]
13. Near-infrared emitting fluorescent homobimetallic gold(I) complexes displaying promising in vitro and in vivo therapeutic properties.
Lescure R; Privat M; Pliquett J; Massot A; Baffroy O; Busser B; Bellaye PS; Collin B; Denat F; Bettaïeb A; Sancey L; Paul C; Goze C; Bodio E
Eur J Med Chem; 2021 Aug; 220():113483. PubMed ID: 33915372
[TBL] [Abstract][Full Text] [Related]
14. 2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1).
Bian J; Deng B; Xu L; Xu X; Wang N; Hu T; Yao Z; Du J; Yang L; Lei Y; Li X; Sun H; Zhang X; You Q
Eur J Med Chem; 2014 Jul; 82():56-67. PubMed ID: 24874653
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone.
Tsao YC; Chang YJ; Wang CH; Chen L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575541
[TBL] [Abstract][Full Text] [Related]
16. Construction of Dual Stimuli-Responsive Platinum(IV) Hybrids with NQO1 Targeting Ability and Overcoming Cisplatin Resistance.
Fang L; Qin X; Zhao J; Gou S
Inorg Chem; 2019 Feb; 58(3):2191-2200. PubMed ID: 30657321
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugs.
Phillips RM; Jaffar M; Maitland DJ; Loadman PM; Shnyder SD; Steans G; Cooper PA; Race A; Patterson AV; Stratford IJ
Biochem Pharmacol; 2004 Dec; 68(11):2107-16. PubMed ID: 15498501
[TBL] [Abstract][Full Text] [Related]
18. Spatio-Temporally Reporting Dose-Dependent Chemotherapy via Uniting Dual-Modal MRI/NIR Imaging.
Ma Y; Yan C; Guo Z; Tan G; Niu D; Li Y; Zhu WH
Angew Chem Int Ed Engl; 2020 Nov; 59(47):21143-21150. PubMed ID: 32729980
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Enzyme-Responsive Profluorophore and Prodrug Nanoparticles for Tumor-Specific Imaging and Precise Chemotherapy.
Pei Q; Lu S; Zhou J; Jiang B; Li C; Xie Z; Jing X
ACS Appl Mater Interfaces; 2021 Dec; 13(50):59708-59719. PubMed ID: 34879654
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological activity of 1,4-quinone moiety attached to betulin derivatives as potent DT-diaphorase substrate.
Kadela-Tomanek M; Jastrzębska M; Marciniec K; Chrobak E; Bębenek E; Latocha M; Kuśmierz D; Boryczka S
Bioorg Chem; 2021 Jan; 106():104478. PubMed ID: 33272711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]